Sandy Spring Bank’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$46.1K Sell
636
-850
-57% -$61.6K ﹤0.01% 589
2024
Q4
$110K Sell
1,486
-182
-11% -$13.5K ﹤0.01% 444
2024
Q3
$110K Sell
1,668
-73
-4% -$4.82K ﹤0.01% 447
2024
Q2
$161K Sell
1,741
-1,169
-40% -$108K 0.01% 390
2024
Q1
$278K Hold
2,910
0.01% 337
2023
Q4
$222K Hold
2,910
0.01% 348
2023
Q3
$202K Hold
2,910
0.01% 343
2023
Q2
$275K Sell
2,910
-1,054
-27% -$99.4K 0.01% 320
2023
Q1
$328K Buy
3,964
+1,046
+36% +$86.5K 0.02% 287
2022
Q4
$218K Buy
2,918
+80
+3% +$5.97K 0.01% 326
2022
Q3
$234K Buy
2,838
+1,203
+74% +$99.2K 0.01% 310
2022
Q2
$155K Sell
1,635
-8
-0.5% -$758 0.01% 351
2022
Q1
$193K Buy
1,643
+50
+3% +$5.87K 0.01% 336
2021
Q4
$206K Hold
1,593
0.01% 332
2021
Q3
$180K Hold
1,593
0.01% 342
2021
Q2
$165K Buy
1,593
+672
+73% +$69.6K 0.01% 357
2021
Q1
$77K Sell
921
-174
-16% -$14.5K ﹤0.01% 450
2020
Q4
$100K Buy
1,095
+234
+27% +$21.4K 0.01% 387
2020
Q3
$69K Sell
861
-9
-1% -$721 ﹤0.01% 422
2020
Q2
$60K Hold
870
﹤0.01% 432
2020
Q1
$54K Hold
870
﹤0.01% 426
2019
Q4
$67K Buy
870
+420
+93% +$32.3K ﹤0.01% 429
2019
Q3
$33K Buy
450
+93
+26% +$6.82K ﹤0.01% 534
2019
Q2
$22K Buy
357
+51
+17% +$3.14K ﹤0.01% 592
2019
Q1
$19K Buy
306
+174
+132% +$10.8K ﹤0.01% 588
2018
Q4
$7K Hold
132
﹤0.01% 695
2018
Q3
$8K Hold
132
﹤0.01% 691
2018
Q2
$6K Hold
132
﹤0.01% 703
2018
Q1
$6K Sell
132
-300
-69% -$13.6K ﹤0.01% 729
2017
Q4
$16K Sell
432
-900
-68% -$33.3K ﹤0.01% 618
2017
Q3
$49K Sell
1,332
-942
-41% -$34.7K ﹤0.01% 444
2017
Q2
$89K Hold
2,274
0.01% 370
2017
Q1
$72K Buy
2,274
+1,200
+112% +$38K 0.01% 403
2016
Q4
$33K Buy
1,074
+132
+14% +$4.06K ﹤0.01% 502
2016
Q3
$38K Hold
942
﹤0.01% 477
2016
Q2
$31K Sell
942
-600
-39% -$19.7K ﹤0.01% 515
2016
Q1
$45K Hold
1,542
0.01% 452
2015
Q4
$41K Buy
+1,542
New +$41K ﹤0.01% 451
2014
Q1
Sell
-2,256
Closed -$25K 744
2013
Q4
$25K Sell
2,256
-180
-7% -$2K ﹤0.01% 449
2013
Q3
$28K Sell
2,436
-2,400
-50% -$27.6K ﹤0.01% 415
2013
Q2
$54K Buy
+4,836
New +$54K 0.01% 341